NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free SOLV Stock Alerts $62.04 -0.34 (-0.55%) (As of 02:39 PM ET) Add Compare Share Share Today's Range$61.85▼$62.8250-Day Range N/A52-Week Range$60.57▼$96.05Volume732,556 shsAverage Volume2.72 million shsMarket Capitalization$10.71 billionP/E RatioN/ADividend YieldN/APrice Target$69.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsSocial Media Get Solventum alerts: Email Address Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself About SolventumSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Read More SOLV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SOLV Stock News HeadlinesMay 13, 2024 | marketbeat.com3 Affordable Stocks That Won’t Stay Down Much Longer (SOLV)Three stocks have fallen into value investor radars, as they provide double-digit discounts to their peers and still generate above-average returns on capitalMay 17 at 4:40 PM | seekingalpha.comSolventum: A Reasonable Start, Still Some Questions To Be AskedMay 16, 2024 | investorplace.comDivide and Conquer: 3 Stock Spinoffs Set to Trounce the MarketMay 14, 2024 | americanbankingnews.comBank of America Initiates Coverage on Solventum (NYSE:SOLV)May 11, 2024 | finance.yahoo.comDecoding Solventum Corp (SOLV): A Strategic SWOT InsightMay 10, 2024 | msn.comB of A Securities Initiates Coverage of Solventum (SOLV) with Neutral RecommendationMay 9, 2024 | finance.yahoo.comUnit Corporation Reports First Quarter ResultsMay 9, 2024 | msn.com3M health care spinoff Solventum prioritizing paying down $8.3B long-term debtMay 9, 2024 | finance.yahoo.comSolventum's first-quarter profit falls 19% on lower surgical product salesMay 9, 2024 | barrons.comSolventum Reports Earnings. There Will Be No Dividend.May 9, 2024 | investorplace.comSOLV Stock Earnings: Solventum Beats EPS, Misses Revenue for Q1 2024May 9, 2024 | prnewswire.comSolventum Reports First Quarter 2024 Financial Results and Capital Allocation UpdateMay 6, 2024 | investorplace.comInvestor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?May 2, 2024 | msn.com3M beats profit estimates on improved electronics demandMay 2, 2024 | msn.com3M to Cut Dividend on Health-Care Spin, Losing Aristocrat StatusMay 2, 2024 | msn.com3M Is ‘Resetting’ Its Dividend. Why Its Stock Is Soaring.May 1, 2024 | msn.comA 'leaner' 3M emerges as CEO hands off company to new leaderApril 30, 2024 | msn.com3M Non-GAAP EPS of $2.39 beats by $0.28, revenue of $7.7B beats by $40MApril 29, 2024 | msn.com3M Earnings Are Almost Here. Expect Big Changes.April 25, 2024 | markets.businessinsider.comSolventum Corporation: Hold Rating Justified Amid Market Stability and Competitive ChallengesApril 24, 2024 | fool.comAlbemarle (NYSE: ALB)April 23, 2024 | prnewswire.comSolventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor EventsApril 16, 2024 | morningstar.comSolvac SA SOLVApril 16, 2024 | fool.comFigs (NYSE: FIGS)April 15, 2024 | prnewswire.comSolventum Names Shirley Edwards to Board of DirectorsSee More Headlines Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today5/20/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:SOLV Previous Symbol: CUSIPN/A CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$69.67 High Stock Price Target$70.00 Low Stock Price Target$69.00 Potential Upside/Downside+12.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio9.91 P/E Growth1.42Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.16 Current Ratio1.81 Quick Ratio1.33 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares172,710,000Free FloatN/AMarket Cap$10.71 billion OptionableOptionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Bryan C. Hanson (Age 57)CEO & Director Mary T. WilcoxChief Accounting OfficerMs. Amy LanducciChief Information & Digital OfficerMr. Paul S. HarringtonChief Supply Chain OfficerMichael J. OttesenVice PresidentKey CompetitorsTeleflexNYSE:TFXShockwave MedicalNASDAQ:SWAVGlobus MedicalNYSE:GMEDInsuletNASDAQ:PODDPenumbraNYSE:PENView All CompetitorsInstitutional OwnershipWalleye Trading LLCBought 106,000 shares on 5/17/2024Ownership: 0.000%Magnetar Financial LLCBought 50,000 shares on 5/15/2024Ownership: 0.029%Alpine Global Management LLCBought 25,398 shares on 5/15/2024Ownership: 0.015%GABELLI & Co INVESTMENT ADVISERS INC.Bought 3,000 shares on 5/15/2024Ownership: 0.002%LRI Investments LLCBought 618 shares on 5/15/2024Ownership: 0.000%View All Institutional Transactions SOLV Stock Analysis - Frequently Asked Questions Should I buy or sell Solventum stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Solventum in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SOLV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SOLV, but not buy additional shares or sell existing shares. View SOLV analyst ratings or view top-rated stocks. What is Solventum's stock price target for 2024? 4 brokerages have issued 1 year target prices for Solventum's stock. Their SOLV share price targets range from $69.00 to $70.00. On average, they anticipate the company's stock price to reach $69.67 in the next twelve months. This suggests a possible upside of 12.0% from the stock's current price. View analysts price targets for SOLV or view top-rated stocks among Wall Street analysts. How have SOLV shares performed in 2024? Solventum's stock was trading at $66.90 at the beginning of the year. Since then, SOLV stock has decreased by 7.0% and is now trading at $62.23. View the best growth stocks for 2024 here. When is Solventum's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our SOLV earnings forecast. How were Solventum's earnings last quarter? Solventum Co. (NYSE:SOLV) released its earnings results on Thursday, May, 9th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $1.67 by $0.41. The business had revenue of $2.02 billion for the quarter, compared to analysts' expectations of $1.99 billion. What ETFs hold Solventum's stock? ETFs with the largest weight of Solventum (NYSE:SOLV) stock in their portfolio include Invesco S&P Spin-Off ETF (CSD), Leatherback Long/Short Alternative Yield ETF (LBAY), First Trust S&P 500 Diversified Free Cash Flow ETF (FCFY) and Pacer BioThreat Strategy ETF (VIRS).Global X Dow 30 Covered Call ETF (DJIA). What guidance has Solventum issued on next quarter's earnings? Solventum updated its FY 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share guidance of 6.100-6.400 for the period, compared to the consensus estimate of 6.270. The company issued revenue guidance of -. Who are Solventum's major shareholders? Solventum's stock is owned by a variety of institutional and retail investors. Top institutional investors include Walleye Trading LLC (0.00%), Price T Rowe Associates Inc. MD (0.05%), Mitsubishi UFJ Trust & Banking Corp (0.05%), Magnetar Financial LLC (0.03%), Alpine Global Management LLC (0.01%) and Fifth Lane Capital LP (0.01%). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SOLV) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestThis military-backed stock “owns” AI marketPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.